Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Robert A Bermel"'
Autor:
Justin R Abbatemarco MD, Jennifer Hartman BSc, Marisa McGinley DO, Robert A Bermel MD, Adrienne Boissy MD, Desiree T Chizmadia BSc, Amy B Sullivan PsyD, Mary R Rensel MD
Publikováno v:
Journal of Patient Experience, Vol 8 (2021)
The coronavirus disease 2019 (COVID-19) pandemic has catalyzed the rapid adoption of telemedicine which encompasses synchronous and asynchronous interactions between patients and providers. In order to facilitate this rapid deployment, there has been
Externí odkaz:
https://doaj.org/article/80e74337043d488da09d4f3e0a899e11
Autor:
Laura Airas, Robert A. Bermel, Tanuja Chitnis, Hans-Peter Hartung, Jin Nakahara, Olaf Stuve, Mitzi J. Williams, Bernd C. Kieseier, Heinz Wiendl
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Bruton’s tyrosine kinase (BTK) inhibitors are an emerging class of therapeutics in multiple sclerosis (MS). BTK is expressed in B-cells and myeloid cells, key progenitors of which include dendritic cells, microglia and macrophages, integral effecto
Externí odkaz:
https://doaj.org/article/e3efcb2e0b04417cb13665a1b2416894
Autor:
Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, Matthew D. Smith, Maria Reyes‐Mantilla, Carrie M. Hersh, Megan H. Hyland, Ryan Canissario, Sarah B. Simmons, Georgina Arrambide, Xavier Montalban, Manuel Comabella, Robert T. Naismith, Min Qiao, Lauren B. Krupp, Jacqueline A. Nicholas, Katja Akgün, Tjalf Ziemssen, Richard Rudick, Elizabeth Fisher, Robert A. Bermel, Ellen M. Mowry, Peter A. Calabresi
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 1, Pp 84-97 (2023)
Abstract Objective Evaluation of serum neurofilament light chain (sNfL), measured using high‐throughput assays on widely accessible platforms in large, real‐world MS populations, is a critical step for sNfL to be utilized in clinical practice. Me
Externí odkaz:
https://doaj.org/article/af7dafcddd2344fa8cf6fe2ae367d591
Autor:
Quanri Zhang, Weiwei Liu, Han Wang, Hao Zhou, Katarzyna Bulek, Xing Chen, Cun-Jin Zhang, Junjie Zhao, Renliang Zhang, Caini Liu, Zizhen Kang, Robert A. Bermel, George Dubyak, Derek W. Abbott, Tsan Sam Xiao, Laura E. Nagy, Xiaoxia Li
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
Mincle is a pattern recognition receptor that senses danger signals in innate immune cells. Here authors show in an experimental autoimmune encephalomyelitis mouse model that tissue damage triggers Mincle signaling on inflammatory helper T cells, lea
Externí odkaz:
https://doaj.org/article/9dba327f0fa94c719a5ed5ddd82cfffe
Autor:
Ellen M. Mowry, Robert A. Bermel, James R. Williams, Tammie L. S. Benzinger, Carl de Moor, Elizabeth Fisher, Carrie M. Hersh, Megan H. Hyland, Izlem Izbudak, Stephen E. Jones, Bernd C. Kieseier, Hagen H. Kitzler, Lauren Krupp, Yvonne W. Lui, Xavier Montalban, Robert T. Naismith, Jacqueline A. Nicholas, Fabio Pellegrini, Alex Rovira, Maximilian Schulze, Björn Tackenberg, Mar Tintore, Madalina E. Tivarus, Tjalf Ziemssen, Richard A. Rudick
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the first example of a learning health system in multiple sclerosis (MS). This paper describes the initial implementation of MS PATHS and initial patient
Externí odkaz:
https://doaj.org/article/6b4c3e31f7a34f3896819caba214808c
Autor:
Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, Matthew D. Smith, Maria Reyes‐Mantilla, Carrie M. Hersh, Megan H. Hyland, Ryan Canissario, Sarah B. Simmons, Georgina Arrambide, Xavier Montalban, Manuel Comabella, Robert T. Naismith, Min Qiao, Lauren B. Krupp, Jacqueline A. Nicholas, Katja Akgün, Tjalf Ziemssen, Richard Rudick, Elizabeth Fisher, Robert A. Bermel, Ellen M. Mowry, Peter A. Calabresi
Publikováno v:
Scientia
Esclerosi múltiple; Cadena lleugera de neurofilaments sèrics Esclerosis múltiple; Cadena ligera de neurofilamentos séricos Multiple sclerosis; Serum neurofilament light chain Objective Evaluation of serum neurofilament light chain (sNfL), measure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf463c953af25086d8f483cbbaa74aa
https://doi.org/10.1002/acn3.51704
https://doi.org/10.1002/acn3.51704
Publikováno v:
Academic Radiology. 28:1733-1738
Previous studies have reported mixed results regarding whether the use of structured reporting (SR) leads to a change in interpretation times. The objective of this study was to quantify any change in interpretation times after the implementation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a041721b75e148a3fad8e84ee157a80
https://doi.org/10.1016/j.acra.2020.08.006
https://doi.org/10.1016/j.acra.2020.08.006
Autor:
Anson B. Rosenfeldt, Steven J. Shook, Robert A. Bermel, Hubert H. Fernandez, Marisa P. McGinley, Andre G. Machado, Mandy Miller Koop, Amanda L. Penko, Jay L. Alberts
Publikováno v:
Parkinson's Disease
Parkinson's Disease, Vol 2021 (2021)
Parkinson's Disease, Vol 2021 (2021)
Introduction. To overcome travel restrictions during the COVID-19 pandemic, consumer-based technology was rapidly deployed to the smartphones of individuals with Parkinson’s disease (PD) participating in a 12-month exercise trial. The aim of the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a36e3c4a3450c94099bc83cacb6f63
https://doi.org/10.1155/2021/5534282
https://doi.org/10.1155/2021/5534282
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
Autor:
Andrew D. Goodman, Eric C. Klawiter, Robert A. Bermel, Marianne Chase, Paola Raska, Victoria Konig, Robert J. Fox, Jens Kuhle, Matthew Karafa, Christian Barro, Robert T. Naismith, Christopher S. Coffey
Publikováno v:
Mult Scler
Background: Sensitive and specific biomarkers for use in progressive multiple sclerosis (MS) have not been established. We investigate neurofilament light (NfL) as a treatment response biomarker in progressive MS. Objective: To evaluate whether ibudi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f57dae4df06d53cf471a2c0e5c2d7ec4
https://doi.org/10.1177/1352458520986956
https://doi.org/10.1177/1352458520986956
Autor:
Ann D Bass, Deidre Kile, Scott D. Newsome, Gabriel Pardo, B Musch, Robert A. Bermel, Pavle Repovic, Ashish Pradhan, J. W. Lindsey, Aram Zabeti, Emmanuelle Waubant
Publikováno v:
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, Vol 8, Iss 3, Pp 711-715 (2021)
Annals of Clinical and Translational Neurology, Vol 8, Iss 3, Pp 711-715 (2021)
The CHORDS trial evaluated ocrelizumab (OCR) in patients with relapsing‐remitting multiple sclerosis who had a suboptimal response to previous disease‐modifying treatment. The objective of the present study was to assess the safety of shorter OCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8483131f709532fc89f8416e3e7fd9
http://europepmc.org/articles/PMC7951110
http://europepmc.org/articles/PMC7951110